Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease that makes it difficult for sufferers to breathe, causing coughing, wheezing, shortness of breath and other symptoms. Affecting as many as 24 million people in the United States, the disease gradually worsens over time and is currently without a cure. Existing treatments can provide only moderate relief of symptoms.

aThrough a partnership with the private sector, the National Heart, Lung, and Blood Institute (NHLBI) is conducting SPIROMICS—an observational study of COPD, which aims to identify subgroups of COPD patients for enrollment in future therapeutic clinical trials, and to identify and perform preliminary validation of intermediate biological and clinical outcomes for use as clinical trial endpoints.

Get involved. Partner with us.

To learn more about partnership opportunities with the SPIROMICS project, contact us:

Julie Wolf-Rodda, Director of Partnership Development
Phone: (301) 402-5311
E-mail: jwolf-rodda [at] fnih [dot] org